Mesenchymal stem cells (especially adipose derived) and their secretome actively rebuild and rejuvenate skin. They stimulate collagen and elastic fiber production, enhance dermal density, and improve hydration and capillary density, leading to smoother texture and more youthful appearance (Jo et al., 2021; Surowiecka & Strużyna, 2022). In clinical aesthetic contexts, ADSC rich preparations have been associated with visibly improved skin quality after facial rejuvenation procedures (Surowiecka & Strużyna, 2022).
In wound related aesthetics, MSCs accelerate closure, promote neovascularization, and reduce fibrosis, so scars are often flatter, softer, and more similar to surrounding skin (Wu et al., 2024; Bian et al., 2022; Guillamat-Prats, 2021). Systematic reviews of chronic wounds and soft tissue defects show AD MSCs enhance healing and tissue volume restoration with good cosmetic outcomes and no major adverse events reported (Bian et al., 2022; Gentile & Garcovich, 2021). For hypertrophic and keloid scars, all in vivo studies reviewed showed improvements in macroscopic and histologic appearance after MSC or MSC conditioned media, without complications (Bojanic et al., 2021).
Hair restoration is another positive area: MSC conditioned media and secretome stimulate hair follicle activity and regrowth, with favorable cosmetic results in both preclinical and early clinical work (Zare et al., 2025; Montero‐Vílchez et al., 2021). Across more than 100 studies, MSC conditioned medium improved wound healing, hair restoration, and skin rejuvenation in animals and humans (Montero‐Vílchez et al., 2021).
A particularly encouraging development is cell free MSC therapy: conditioned media, secretome, and extracellular vesicles. These products reproduce many of the regenerative, pro-angiogenic, and anti-inflammatory benefits of live cells while reducing risks related to cell engraftment or immune reactions (Zare et al., 2025; Bian et al., 2022; Jung et al., 2024; L et al., 2019). Reviews emphasize their lower immunogenicity and diminished risk of tumor formation or thrombosis compared with whole cell infusions, which is very attractive for aesthetic indications where long-term safety is paramount (Bian et al., 2022; Montero‐Vílchez et al., 2021; Jung et al., 2024; L et al., 2019).
Clinical and preclinical studies consistently describe favorable outcomes and good tolerability for MSC conditioned media in skin rejuvenation, scars, and hair growth (Zare et al., 2025; Zhu et al., 2025; Montero‐Vílchez et al., 2021).
| Application / Product | Typical Benefits | Safety Profile (Reported) | Citations |
|---|---|---|---|
| ADSC based facial rejuvenation | Better dermal density, hydration, vascularity, overall appearance | Mostly mild, transient local effects | (Jo et al., 2021; Surowiecka & Strużyna, 2022; Gentile & Garcovich, 2021) |
| Chronic wounds / scars | Faster closure, less fibrosis, better cosmetic quality | No major adverse events in clinical series | (Wu et al., 2024; Bian et al., 2022; Gentile & Garcovich, 2021; Guillamat-Prats, 2021; Bojanic et al., 2021) |
| Hair restoration (MSC CM/secretome) | Increased hair regrowth, thicker shafts | Well tolerated in available studies | (Zare et al., 2025; Zhu et al., 2025; Montero‐Vílchez et al., 2021) |
| MSC CM / EVs for skin | Anti-inflammatory, pro-angiogenic, anti-scarring | Lower immunogenicity and tumor risk than cells | (Zare et al., 2025; Bian et al., 2022; Zhu et al., 2025; Jung et al., 2024; L et al., 2019) |
Figure: Regenerative benefits and generally favorable safety of MSC aesthetics.
Across regenerative and aesthetic indications, MSC-based and secretome-based treatments have shown reassuring safety in controlled settings, with adverse events typically mild (local swelling, bruising, transient discomfort) and serious complications rare when techniques follow best practice (Surowiecka & Strużyna, 2022; Bian et al., 2022; Gentile & Garcovich, 2021). Cell-free products are particularly promising for aesthetics because they retain potent regenerative signaling while naturally sidestepping many cell-related concerns such as engraftment, immune rejection, or uncontrolled proliferation (Bian et al., 2022; Montero‐Vílchez et al., 2021; Jung et al., 2024; L et al., 2019).
Current limitations, like variability in cell sources, preparation methods, and dosing, are best viewed as opportunities for optimization. Recent systematic reviews stress that standardizing manufacturing and characterization will likely make these therapies even more predictable, scalable, and safe for routine aesthetic practice (Wu et al., 2024; Zhu et al., 2025; Jung et al., 2024; Prado-Yupanqui et al., 2025; Aghayan et al., 2025). As protocols become more harmonized and larger clinical trials are completed, the strong regenerative and cosmetic potential already documented suggests MSC-based and especially MSC-derived, cell-free approaches can become a cornerstone of modern, biologically oriented aesthetic medicine.
Zare, S., Jafarzadeh, A., Zare, S., & Shamloo, A. (2025). Exploring the dermatological applications of human mesenchymal stem cell secretome: a comprehensive review. Stem Cell Research & Therapy, 16. https://doi.org/10.1186/s13287-025-04311-8
Jo, H., Brito, S., Kwak, B., Park, S., Lee, M., & Bin, B. (2021). Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation. International Journal of Molecular Sciences, 22. https://doi.org/10.3390/ijms22052410
Wu, S., Sun, S., Fu, W., Yang, Z., Yao, H., & Zhang, Z. (2024). The Role and Prospects of Mesenchymal Stem Cells in Skin Repair and Regeneration. Biomedicines, 12. https://doi.org/10.3390/biomedicines12040743
Surowiecka, A., & Strużyna, J. (2022). Adipose-Derived Stem Cells for Facial Rejuvenation. Journal of Personalized Medicine, 12. https://doi.org/10.3390/jpm12010117
Bian, D., Wu, Y., Song, G., Azizi, R., & Zamani, A. (2022). The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review. Stem Cell Research & Therapy, 13. https://doi.org/10.1186/s13287-021-02697-9
Zhu, Y., Yang, H., Xue, Z., Tang, H., Chen, X., & Liao, Y. (2025). Mesenchymal stem cells-derived small extracellular vesicles and apoptotic extracellular vesicles for wound healing and skin regeneration: a systematic review and meta-analysis of preclinical studies. Journal of Translational Medicine, 23. https://doi.org/10.1186/s12967-024-05744-0
Montero‐Vílchez, T., Sierra-Sánchez, Á., Sánchez-Díaz, M., Quiñones-Vico, M., Sanabria-De-La-Torre, R., Martínez-López, A., & Arias-Santiago, S. (2021). Mesenchymal Stromal Cell-Conditioned Medium for Skin Diseases: A Systematic Review. Frontiers in Cell and Developmental Biology, 9. https://doi.org/10.3389/fcell.2021.654210
Jung, H., Jung, Y., Seo, J., Bae, Y., Kim, H., & Jeong, W. (2024). Roles of extracellular vesicles from mesenchymal stem cells in regeneration. Molecules and Cells, 47. https://doi.org/10.1016/j.mocell.2024.100151
Gentile, P., & Garcovich, S. (2021). Systematic Review: Adipose-Derived Mesenchymal Stem Cells, Platelet-Rich Plasma and Biomaterials as New Regenerative Strategies in Chronic Skin Wounds and Soft Tissue Defects. International Journal of Molecular Sciences, 22. https://doi.org/10.3390/ijms22041538
Prado-Yupanqui, J., Ramírez-Orrego, L., Cortez, D., Vera-Ponce, V., Chenet, S., Tejedo, J., & Tapia-Limonchi, R. (2025). The Hidden Power of the Secretome: Therapeutic Potential on Wound Healing and Cell-Free Regenerative Medicine—A Systematic Review. International Journal of Molecular Sciences, 26. https://doi.org/10.3390/ijms26051926
Guillamat-Prats, R. (2021). The Role of MSC in Wound Healing, Scarring and Regeneration. Cells, 10. https://doi.org/10.3390/cells10071729
Bojanic, C., To, K., Hatoum, A., Shea, J., Seah, K., Khan, W., & Malata, C. (2021). Mesenchymal stem cell therapy in hypertrophic and keloid scars. Cell and Tissue Research, 383, 915 - 930. https://doi.org/10.1007/s00441-020-03361-z
Aghayan, A., Mohammadi, D., Atashi, A., & Jamalpoor, Z. (2025). Synergistic effects of mesenchymal stem cells and their secretomes with scaffolds in burn wound healing: a systematic review and meta-analysis of preclinical studies. Journal of Translational Medicine, 23. https://doi.org/10.1186/s12967-025-06712-y
L, P., Kandoi, S., Misra, R., S., V., K, R., & Verma, R. (2019). The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine & Growth Factor Reviews, 46, 1-9. https://doi.org/10.1016/j.cytogfr.2019.04.002